Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 609-613

  Brun, Valérie ^a   Bastian, Hervé ^a   Neveu, Virginie ^a   Foussat, Arnaud ^a  

^a TxCell SA   (France)

Author keywords

Crohn's disease; Immunotherapy; Regulatory Tr1 cells

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; LEUKOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CELL THERAPY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE SEVERITY; DROSOPHILA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CELL CLONE; CELL PROLIFERATION; CLINICAL PROTOCOL; IMMUNOLOGY; IMMUNOPHENOTYPING; KARYOTYPING; METABOLISM; MOUSE; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; ANTIGENS, CD; CELL PROLIFERATION; CLINICAL PROTOCOLS; CLONE CELLS; CROHN DISEASE; CYTOKINES; DROSOPHILA; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; KARYOTYPING; MICE; OVALBUMIN; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, REGULATORY;

EID: 63549084142     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.032     Document Type: Article

References (17)

1. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 6652 (Oct 16 1997) 737-742
2. + T cells in the control of inflammation. J Immunol 171 10 (Nov 15 2003) 5018-5026
3. Cong Y., Weaver C.T., Lazenby A., and Elson C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169 11 (Dec 1 2002) 6112-6119
4. Maurer M., Seidel-Guyenot W., Metz M., Knop J., and Steinbrink K. Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest 112 3 (Aug 2003) 432-439
5. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199 11 (Jun 7 2004) 1567-1575
6. Akdis M. T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther 8 6 (Jun 2008) 769-777
7. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., et al. interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195 5 (Mar 4 2002) 603-616
8. Mallat Z., Gojova A., Brun V., Esposito B., Fournier N., Cottrez F., et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation 108 10 (Sep 9 2003) 1232-1237
9. You S., Chen C., Lee W.H., Brusko T., Atkinson M., and Liu C.P. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J Immunol 173 11 (Dec 1 2004) 6777-6785
10. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. Aug 2006;212:28-50. Review.
11. Peyrin-Biroulet L., Desreumaux P., Sandborn W.J., and Colombel J.F. Crohn's disease: beyond antagonists of tumour necrosis factor. Lancet 372 9632 (Jul 5 2008) 67-81
12. Velayos F.S., and Sandborn W.J. Positioning biologic therapy for Crohn's disease and ulcerative colitis. Curr Gastroenterol Rep 9 6 (Dec 2007) 521-527
13. Decary S., Mouly V., Hamida C.B., Sautet A., Barbet J.P., and Butler-Browne G.S. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8 12 (Aug 10 1997) 1429-1438
14. + T cells. Proc Natl Acad Sci U S A 93 25 (Dec 10 1996) 14736-14741
15. + T cells: implications for tumor immunotherapy. Immunity 4 6 (Jun 1996) 555-564
16. Battaglia M., Gianfrani C., Gregori S., and Roncarolo M.G. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 1029 (Dec 2004) 142-153
17. Huibregtse I.L., Snoeck V., de Creus A., Braat H., De Jong E.C., Van Deventer S.J., et al. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133 2 (Aug 2007) 517-528